Your browser doesn't support javascript.
loading
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib.
Casadei-Gardini, Andrea; Dadduzio, Vincenzo; Rovesti, Giulia; Cabibbo, Giuseppe; Vukotic, Ranka; Rizzato, Mario Domenico; Orsi, Giulia; Rossi, Margherita; Guarneri, Valeria; Lonardi, Sara; D'agostino, Dario; Celsa, Ciro; Andreone, Pietro; Zagonel, Vittorina; Scartozzi, Mario; Cascinu, Stefano; Cucchetti, Alessandro.
Afiliación
  • Casadei-Gardini A; Unit of Oncology, Department of Oncology, University Hospital of Modena and Reggio Emilia, Modena.
  • Dadduzio V; Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova.
  • Rovesti G; Unit of Oncology, Department of Oncology, University Hospital of Modena and Reggio Emilia, Modena.
  • Cabibbo G; Section of Gastroenterology and Hepatology, Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo.
  • Vukotic R; Hepatology Unit, AOU Policlinico di Sant'Orsola and University of Bologna, Bologna.
  • Rizzato MD; Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova.
  • Orsi G; Unit of Surgery, Oncology and Gastroenterology, University of Padova, Padua.
  • Rossi M; Unit of Oncology, Department of Oncology, University Hospital of Modena and Reggio Emilia, Modena.
  • Guarneri V; Section of Gastroenterology and Hepatology, Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo.
  • Lonardi S; Hepatology Unit, AOU Policlinico di Sant'Orsola and University of Bologna, Bologna.
  • D'agostino D; Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova.
  • Celsa C; Section of Gastroenterology and Hepatology, Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo.
  • Andreone P; Section of Gastroenterology and Hepatology, Dipartimento di Promozione della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo.
  • Zagonel V; Hepatology Unit, AOU Policlinico di Sant'Orsola and University of Bologna, Bologna.
  • Scartozzi M; Division of Internal and Metabolic Medicine, AOU Modena and University of Modena e Reggio Emilia, Modena.
  • Cascinu S; Medical Oncology Unit 1, Istituto Oncologico Veneto IRCCS, Padova.
  • Cucchetti A; Department of Medical Oncology, University of Cagliari, Cagliari, Italy.
Medicine (Baltimore) ; 99(22): e19958, 2020 May 29.
Article en En | MEDLINE | ID: mdl-32481366
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sobrevivientes / Carcinoma Hepatocelular / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sobrevivientes / Carcinoma Hepatocelular / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article